| Dual-target iTBS for Youth With ADHD (NCT07084649) | Shanghai Mental Health Center | 2025-01-01 |
| A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty (NCT06070532) | Cellcolabs Clinical LTD. | 2025-01-01 |
| Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC (NCT06547424) | Indiana University | 2025-01-01 |
| A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors (NCT06755242) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-01-01 |
| Psychedelic-assisted Group Program for First Responders (NCT06471959) | Empower Research Inc | 2025-01-01 |
| FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation (NCT06409637) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-01-01 |
| IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma (NCT06757881) | Shanghai Zhongshan Hospital | 2025-01-01 |
| Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution (NCT07226726) | The Foundation for Orthopaedics and Regenerative Medicine | 2025-01-01 |
| Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis (NCT06590545) | David Simon | 2025-01-01 |
| Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML (NCT04973618) | Aptevo Therapeutics | 2025-01-01 |
| Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes (NCT06996717) | Ain Shams University | 2025-01-01 |
| Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants. (NCT06782659) | Aspargo Labs, Inc | 2025-01-01 |
| Learn About Caring for a Person Living With Dementia (NCT07381010) | Texas Christian University | 2025-01-01 |
| Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors (NCT06652529) | Aromics Therapeutics | 2025-01-01 |
| Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma (NCT07508605) | Shenzhen University General Hospital | 2025-01-01 |
| Intravenous Hydromorphone for the Treatment of Acute Pain (NCT06949059) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-01-01 |
| Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer (NCT06900647) | Sun Yat-sen University | 2025-01-01 |
| Sphenopalatine Ganglion Block and Cold Induced Headaches (NCT06310200) | Wright State University | 2025-01-01 |
| Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia (NCT04405596) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-01-01 |
| Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT (NCT06303284) | University of Calgary | 2025-01-01 |
| Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors (NCT06742593) | Suzhou Maximum Bio-tech Co., Ltd. | 2025-01-01 |
| Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders (NCT03123458) | Shenzhen Geno-Immune Medical Institute | 2025-01-01 |
| A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects (NCT06800729) | TIXiMED, Inc. | 2025-01-01 |
| Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy (NCT06746961) | The First Affiliated Hospital of Zhengzhou University | 2025-01-01 |
| Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder (NCT05562973) | Johns Hopkins University | 2025-01-01 |
| Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome (NCT06698848) | Massachusetts General Hospital | 2025-01-01 |
| A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases (NCT06774664) | Sinocelltech Ltd. | 2025-01-01 |
| A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment (NCT06677255) | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | 2025-01-01 |
| The Effect of Human Umbilical Cord Mesenchymal Stem Cells and Exosomes on the Healing of Postoperative Pain and Periapical Lesions in the Treatment of Apical Periodontitis: Randomized Controlled Clinical Study (NCT06764004) | TC Erciyes University | 2025-01-01 |
| Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma (NCT06737146) | Suzhou Maximum Bio-tech Co., Ltd. | 2025-01-01 |
| Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy (NCT06602661) | Surrey Thoracic Surgery Group | 2025-01-01 |
| Brain Biomarker on Inflammation Response (NCT03271814) | University of Maryland, Baltimore | 2025-01-01 |
| Ttt of Adenomyosis (NCT06719934) | Al-Azhar University | 2025-01-01 |
| A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. (NCT06883539) | LaunXP Biomedical Co., Ltd. | 2024-12-31 |
| HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients (NCT06885710) | Changhai Hospital | 2024-12-31 |
| Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human (NCT06727838) | Shandong Suncadia Medicine Co., Ltd. | 2024-12-31 |
| CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors (NCT06720324) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-12-31 |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors (NCT06581419) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-12-31 |
| A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors (NCT06783569) | JiaRay Group | 2024-12-31 |
| XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC (NCT06742411) | West China Hospital | 2024-12-31 |
| A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors (NCT06681870) | Astellas Pharma Global Development, Inc. | 2024-12-31 |
| Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer (NCT07035002) | Ruijin Hospital | 2024-12-31 |
| Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM) (NCT06759181) | Xuzhou Medical University | 2024-12-31 |
| Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer (NCT06269978) | Arjun Mittra | 2024-12-31 |
| An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With CapOX and Bevacizumab Regimen for First-line Treatment of Advanced Colorectal Adenocarcinoma With SMAD4R361H/C Mutation. (NCT06753721) | Nanfang Hospital, Southern Medical University | 2024-12-31 |
| A Study of HDM2006 in Patients With Advanced Solid Tumor (NCT07377591) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-12-31 |
| Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer (NCT06616623) | Dwight Owen | 2024-12-31 |
| A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects (NCT06742840) | Shandong Suncadia Medicine Co., Ltd. | 2024-12-30 |
| Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer (NCT06613009) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-12-30 |
| HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies (NCT06649708) | Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | 2024-12-30 |
| ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial (NCT06664879) | M.D. Anderson Cancer Center | 2024-12-30 |
| A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma (NCT06600321) | Alnylam Pharmaceuticals | 2024-12-30 |
| Effect of Honey For CIN II (NCT06219018) | Zuyderland Medisch Centrum | 2024-12-30 |
| A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia (NCT06772766) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2024-12-30 |
| A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma (NCT06734871) | Aibin Liang，MD，Ph.D. | 2024-12-30 |
| Rifaximin SSD in Dementia Trial (NCT06718686) | Jasmohan Bajaj | 2024-12-30 |
| A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection (NCT07183306) | Suzhou HepaThera Biotech Co., Ltd. | 2024-12-30 |
| Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant (NCT05982275) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2024-12-30 |
| A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT07461181) | Ruijin Hospital | 2024-12-30 |
| Clinical Trial to Treat Stage IV Cancer Patients (NCT06674538) | Moonshot Antibodies | 2024-12-30 |
| A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa) (NCT06749457) | AstraZeneca | 2024-12-30 |
| A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors (NCT06710379) | Adcentrx Therapeutics | 2024-12-30 |
| Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors (NCT07415863) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2024-12-30 |
| Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors (NCT06770764) | Trutino Biosciences Inc. | 2024-12-30 |
| Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma (NCT06757387) | Peking University Cancer Hospital & Institute | 2024-12-30 |
| A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring (NCT06788509) | Janssen Research & Development, LLC | 2024-12-30 |
| A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants (NCT06775730) | Shionogi | 2024-12-30 |
| A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (NCT06740019) | Jemincare | 2024-12-28 |
| Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg) (NCT06922253) | Humanis Saglık Anonim Sirketi | 2024-12-28 |
| Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma (NCT06751134) | Nanjing Children's Hospital | 2024-12-28 |
| Adenovirus (RGDCRAdCOX2F) (NCT06693986) | Masonic Cancer Center, University of Minnesota | 2024-12-27 |
| Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma (NCT06516887) | The University of Texas Health Science Center at San Antonio | 2024-12-27 |
| Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors (NCT06566079) | InSilico Medicine Hong Kong Limited | 2024-12-27 |
| A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias (NCT06397027) | M.D. Anderson Cancer Center | 2024-12-27 |
| Relugolix + Enzalutamide Study in High-Risk Prostate Cancer (NCT06130995) | University of Oklahoma | 2024-12-26 |
| Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma (NCT06705725) | Carbiogene Therapeutics Co. Ltd. | 2024-12-26 |
| A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus (NCT06694298) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-12-26 |
| A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants (NCT06729970) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2024-12-26 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects (NCT07703982) | Aquestive Therapeutics | 2024-12-26 |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial (NCT06432036) | Jonsson Comprehensive Cancer Center | 2024-12-26 |
| A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation (NCT06756490) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-12-26 |
| An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer (NCT07444281) | Shanghai AbelZeta Ltd. | 2024-12-25 |
| BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia (NCT06746519) | Chen Suning | 2024-12-25 |
| A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer (NCT06760364) | Tianjin Medical University Cancer Institute and Hospital | 2024-12-25 |
| A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies (NCT06971523) | CytosinLab Therapeutics Co., Ltd. | 2024-12-25 |
| The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. (NCT06764329) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2024-12-25 |
| Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy (NCT06596018) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-12-25 |
| A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. (NCT06718192) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2024-12-25 |
| Evaluation the Safety of hemay005 Tablets (NCT06908642) | Anhui Hemay Pharmaceutical Co., Ltd | 2024-12-25 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study. (NCT07117474) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-12-24 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation (NCT06556394) | Ractigen Therapeutics. | 2024-12-24 |
| Phase 1 BIO 300 Oral Suspension (NCT06741345) | Humanetics Corporation | 2024-12-23 |
| A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults. (NCT06541678) | Pfizer | 2024-12-23 |
| mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer (NCT06761027) | Fujian Provincial Hospital | 2024-12-23 |
| Clinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome (NCT06618495) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2024-12-23 |
| Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors (NCT06735144) | Jiangsu HengRui Medicine Co., Ltd. | 2024-12-23 |
| A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism (NCT06877247) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-12-23 |
| Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets (NCT06932159) | Humanis Saglık Anonim Sirketi | 2024-12-23 |
| A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide (NCT06758583) | Zealand Pharma | 2024-12-23 |
| Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) (NCT07002398) | VeonGen Therapeutics GmbH | 2024-12-23 |